The Board of Morepen Laboratories at its meeting held on 12 May 2025 has noted the decision of the Board of Directors of Morepen Medipath (formerly known as Morepen Medtech), a subsidiary of the Company, to incorporate a Wholly Owned Subsidiary in the mainland at Dubai, United Arab Emirates.
The incorporation of the wholly owned subsidiary is intended to expand both the Business-to-Consumer (B2C) and Business-to-Business (B2B) customer segments and to provide greater access to the medical device business.
Upon incorporation, the proposed company will become a step-down subsidiary of Morepen Laboratories.